Article Information
History
- April 10, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Gustavo Gámez1,2,*,
- Juan A. Hermoso3,
- César Carrasco-López4,
- Alejandro Gómez-Mejia5,
- Carlos E. Muskus6 and
- Sven Hammerschmidt7
- 1Genetics, Regeneration and Cancer (GRC) Research Group, University Research Center (SIU), University of Antioquia, UdeA, 050010 Medellín, Colombia
- 2Basic and Applied Microbiology (MICROBA) Research Group, School of Microbiology, University of Antioquia, UdeA, 050010 Medellín, Colombia
- 3Department of Crystallography and Structural Biology, Institute of Physical Chemistry “Rocasolano”, CSIC, 28006 Madrid, Spain
- 4Department of Chemical and Biological Engineering, Princeton University, Princeton NJ 08544
- 5Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, 8091, Zurich, Switzerland
- 6Program for the Study and Control of Tropical Diseases-PECET, Faculty of Medicine, University of Antioquia, 050010 Medellín, Colombia
- 7Department of Molecular Genetics and Infection Biology, Interfaculty Institute for Genetics and Functional Genomics, Center for Functional Genomics of Microbes, University of Greifswald, 17487 Greifswald, Germany
- ↵*Corresponding author. E-mail: gustavo.gamez{at}udea.edu.co
Posted April 10, 2021.
Atypical N-glycosylation of SARS-CoV-2 impairs the efficient binding of Spike-RBM to the human-host receptor hACE2
